97 related articles for article (PubMed ID: 12206026)
41. TRAIL and chemotherapeutic drugs in cancer therapy.
Wu XX; Ogawa O; Kakehi Y
Vitam Horm; 2004; 67():365-83. PubMed ID: 15110186
[TBL] [Abstract][Full Text] [Related]
42. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
43. 1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance.
Novi M; Ottone M; Dell'Erba C; Barbieri F; Chiavarina B; Maccagno M; Viale M
Oncol Rep; 2004 Jul; 12(1):91-6. PubMed ID: 15201965
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines.
Gapany M; Dawson DE; Schriever C; Burgess R; Gipple JR; Riggs CE
Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):436-9. PubMed ID: 2317326
[TBL] [Abstract][Full Text] [Related]
45. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ
Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731
[TBL] [Abstract][Full Text] [Related]
46. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras K; Rubin K; Sjöblom T; Buchdunger E; Sjöquist M; Heldin CH; Ostman A
Cancer Res; 2002 Oct; 62(19):5476-84. PubMed ID: 12359756
[TBL] [Abstract][Full Text] [Related]
48. Interferon-alpha induces sensitization of cells to inhibition of protein synthesis by tumour necrosis factor-related apoptosis-inducing ligand.
Jeffrey IW; Elia A; Bornes S; Tilleray VJ; Gengatharan K; Clemens MJ
FEBS J; 2006 Aug; 273(16):3698-708. PubMed ID: 16911520
[TBL] [Abstract][Full Text] [Related]
49. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro.
Zhang P; Gao WY; Turner S; Ducatman BS
Mol Cancer; 2003 Jan; 2():1. PubMed ID: 12537587
[TBL] [Abstract][Full Text] [Related]
50. Tumor necrosis factor and chemotherapeutic agents. Potentiation of cytotoxicity with interferon gamma.
Dawson DE; Gapany M; Burgess RC; Boesen PV; Headley DB
Arch Otolaryngol Head Neck Surg; 1992 Nov; 118(11):1168-71. PubMed ID: 1418895
[TBL] [Abstract][Full Text] [Related]
51. Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells.
Giordano M; Ucci G; Riccardi A; Girino M; Danova M; Stella CC; Pedrazzoli P; Cazzola M
Haematologica; 1988; 73(3):187-9. PubMed ID: 3139513
[No Abstract] [Full Text] [Related]
52. Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents.
Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Pomatico G; Bianco AR; Jiang Z; Agrawal S; Ciardiello F
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):141-5. PubMed ID: 9593054
[No Abstract] [Full Text] [Related]
53. Modulation of leukemic cell proliferation by tumor necrosis factor alpha.
Kerim S; Piacibello W; Aglietta M
Haematologica; 1988; 73(5):383-6. PubMed ID: 3143637
[No Abstract] [Full Text] [Related]
54. Effects of interferon and 5-methylthioadenosine on HL60 cell line proliferation.
Pozzato G; Franzin F; Luchesi A; Presani G; Perticarari S
Haematologica; 1990; 75(5):484-5. PubMed ID: 2097270
[No Abstract] [Full Text] [Related]
55. Enhancement of drug sensitivity of human malignancies by epidermal growth factor.
Kröning R; Jones JA; Hom DK; Chuang CC; Sanga R; Los G; Howell SB; Christen RD
Br J Cancer; 1995 Sep; 72(3):615-9. PubMed ID: 7669570
[TBL] [Abstract][Full Text] [Related]
56. Anti-proliferative activity of interferon-alpha on human squamous carcinoma of tongue cell lines.
King WW; Lam PK; Li AK
Cancer Lett; 1994 Sep; 85(1):55-8. PubMed ID: 7923102
[TBL] [Abstract][Full Text] [Related]
57. [Tumor necrosis factor].
Herrmann F; Mertelsmann R
Dtsch Med Wochenschr; 1989 Feb; 114(8):312-6. PubMed ID: 2646094
[No Abstract] [Full Text] [Related]
58. The anti-cancer activity of tumour necrosis factor.
Malik S; Balkwill F
Ann Inst Pasteur Immunol; 1988; 139(3):285-8. PubMed ID: 3048310
[No Abstract] [Full Text] [Related]
59. [Studies on the radio-cystostatic combination therapy. 5. Syncytostatic studies on 5-fluorouracil, Natulan and Proresid].
Ringleb D; Grundner HG; Krieg R; Steckenmesser R
Strahlentherapie; 1969 Jun; 137(6):680-4. PubMed ID: 5355164
[No Abstract] [Full Text] [Related]
60. [Pretesting of drugs using lower and higher plants. II. Effect of phenazetin and various substances frequently combined with it, on the shape and growth of Micrasterias americana].
Paschke M; Schwanitz F
Arzneimittelforschung; 1971 Jun; 21(6):873-6. PubMed ID: 5109281
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
